COVID Risk | Literature database and meta-analysis page 7

Last update : 2021-08-05 08:37:15 (GMT+2) | 276 factors investigated | 1766 estimates included | 219 articles processed | QC progress: 50%

Receive updates on COVID-19 risk factors

Associated factors

Risk category:

Risk name:

Outcomes

Outcome description:

Filters

Adjusted analysis:

Author:

Reset
Run a meta-analysis by selecting an Outcome & a Risk category or a Risk name & a Risk category, and click on the Submit button.

Green: significant protective factor
Red: significant risk factor
^§ adjusted estimate (see article details)
^† estimated using data reported in the article

Outcome	Risk category	Risk [exposed vs. unexposed]	Risk estimate (95% CI)	Author [URL]	View	QC
COVID-19 (severe/critical)	Laboratory Findings	Serum ferritin [>500-1000 vs. 0-300]	Odds ratio: 1.130 (0.830-1.500) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	Serum ferritin [>300-500 vs. 0-300]	Odds ratio: 0.960 (0.670-1.400) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	D-dimer [missing vs. 0-250]	Odds ratio: 0.750 (0.480-1.200) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	D-dimer [>2500 vs. 0-250]	Odds ratio: 3.930 (2.600-6.000) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	D-dimer [>1000-2500 vs. 0-250]	Odds ratio: 2.370 (1.580-3.600) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	D-dimer [>250-500 vs. 0-250]	Odds ratio: 2.260 (1.660-3.100) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	IL-6 [1 unit increase vs. Not applicable]	Odds ratio: 1.090 (1.040-1.147) ^§	Zhu
COVID-19 (severe/critical)	Laboratory Findings	CRP [1 unit increase vs. Not applicable]	Odds ratio: 1.030 (1.005-1.055) ^§	Zhu
COVID-19 (severe/critical)	Comorbidities	Hypertension [Present vs. Not present]	Odds ratio: 4.380 (1.012-18.993) ^§	Zhu
COVID-19 (severe/critical)	Treatment	Concomitant medication [Treated with ACEi/ARB vs. Not received]	Odds ratio: 0.980 (0.870-1.090)	Zhang
COVID-19 (death)	Treatment	Concomitant medication [Treated with ACEi/ARB vs. Not received]	Odds ratio: 0.660 (0.380-1.120) ^§	Zhang
COVID-19 (death)	Treatment	Concomitant medication [Treated with ACEi/ARB vs. Not received]	Odds ratio: 0.730 (0.500-1.070)	Zhang
COVID-19 (infection)	Treatment	Concomitant medication [Treated with ARBs vs. Not received]	Odds ratio: 1.010 (0.950-1.070)	Zhang
COVID-19 (infection)	Treatment	Concomitant medication [Treated with ACEi vs. Not received]	Odds ratio: 0.980 (0.920-1.040)	Zhang
COVID-19 (infection)	Treatment	Concomitant medication [Treated with ACEi/ARB vs. Not received]	Odds ratio: 0.990 (0.950-1.040)	Zhang
COVID-19 (severe/critical)	Laboratory Findings	D-dimer [>250-500 vs. 0-250]	Odds ratio: 1.580 (1.210-2.100) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	CRP [missing vs. 0-15]	Odds ratio: 2.590 (1.100-6.100) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	CRP [>200 vs. 0-15]	Odds ratio: 5.090 (2.820-9.200) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	CRP [>100-200 vs. 0-15]	Odds ratio: 3.860 (2.230-6.700) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	CRP [>15-100 vs. 0-15]	Odds ratio: 2.350 (1.370-4.000) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	Procalcitonin [Abnormal vs. Normal]	Hazard ratio: 4.908 (1.797-13.402) ^§	Liu
COVID-19 (severe/critical)	Laboratory Findings	CRP [Abnormal vs. Normal]	Hazard ratio: 4.394 (1.924-10.033) ^§	Liu
COVID-19 (severe/critical)	Patient characteristics	Age [1 year increase vs. Not applicable]	Hazard ratio: 1.042 (1.015-1.070) ^§	Liu
COVID-19 (severe/critical)	Laboratory Findings	IL-6 [Abnormal vs. Normal]	Hazard ratio: 2.375 (1.058-5.329) ^§	Liu
Coronaviruses (severe/critical)	Treatment	Treatment for coronavirus infection [Treated with corticosteroid vs. Not received]	Risk ratio: 1.330 (0.730-2.420) ^§	Li
Coronaviruses (death)	Treatment	Treatment for coronavirus infection [Treated with corticosteroid vs. Not received]	Risk ratio: 1.070 (0.810-1.420)	Li
Virus clearance	Treatment	Treatment for coronaviruses [Treated with corticosteroid vs. Not received]	Mean Difference: 3.780 (1.160-6.410)	Li
COVID-19 (severe/critical)	Laboratory Findings	Creatinine [missing vs. 0-1.1]	Odds ratio: 1.470 (0.330-6.700) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	Creatinine [>2 vs. 0-1.1]	Odds ratio: 1.660 (1.110-2.500) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	Creatinine [>1.1-2 vs. 0-1.1]	Odds ratio: 1.520 (1.200-1.900) ^§	Petrilli
COVID-19 (severe/critical)	Patient characteristics	Smoking [Present vs. Not present]	Odds ratio: 16.130 (1.275-204.160) ^§	Yu
COVID-19 (severe/critical)	Patient characteristics	BMI [1 unit increase vs. Not applicable]	Odds ratio: 1.285 (1.045-1.581) ^§	Yu
COVID-19 (severe/fatal)	Laboratory Findings	LDH [1 unit increase vs. Not applicable]	Odds ratio: 1.010 (1.001-1.019) ^§	Yu
COVID-19 (severe/critical)	Vital Signs	Systolic blood pressure [1 unit increase vs. Not applicable]	Odds ratio: 1.046 (1.006-1.089) ^§	Yu
COVID-19 (severe/critical)	Patient characteristics	BMI [1 unit increase vs. Not applicable]	Odds ratio: 1.327 (1.038-1.697) ^§	Yu
COVID-19 (severe/critical)	Patient characteristics	Age [1 year increase vs. Not applicable]	Odds ratio: 1.078 (1.020-1.140) ^§	Yu
COVID-19 (severe/critical)	Laboratory Findings	Lymphocyte count [missing vs. >1.2]	Odds ratio: 4.760 (1.020-22.200) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	Lymphocyte count [<0.5 vs. >1.2]	Odds ratio: 1.760 (1.260-2.500) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	Lymphocyte count [0.5-0.8 vs. >1.2]	Odds ratio: 1.190 (0.930-1.500) ^§	Petrilli
COVID-19 (severe/critical)	Laboratory Findings	Lymphocyte count [0.8-1.2 vs. >1.2]	Odds ratio: 1.090 (0.820-1.400) ^§	Petrilli
Hospital discharge	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received]	Risk ratio: 1.000 (0.900-1.200) ^§	Mahévas
COVID-19 (severe/critical)	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received]	Risk ratio: 1.100 (0.900-1.300) ^§	Mahévas
COVID-19 (survival)	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received]	Hazard ratio: 1.200 (0.700-2.200) ^§	Mahévas
COVID-19 (death)	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received]	Hazard ratio: 1.200 (0.500-3.000) ^§	Mahévas
COVID-19 (survival)	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received]	Hazard ratio: 0.800 (0.400-1.500) ^§	Mahévas
COVID-19 (severe/critical)	Vital Signs	Oxygen saturation [<88 vs. >92]	Odds ratio: 3.670 (2.780-4.800) ^§	Petrilli
COVID-19 (severe/critical)	Vital Signs	Oxygen saturation [88-92 vs. >92]	Odds ratio: 1.490 (1.180-1.900) ^§	Petrilli
COVID-19 (death)	Complications	Dementia [Present vs. Not present]	Odds ratio: 1.840 (1.080-3.130) ^§	Bianchetti
COVID-19 (death)	Patient characteristics	Gender [Female vs. Male]	Odds ratio: 0.870 (0.600-1.270) ^§	Bianchetti
COVID-19 (death)	Patient characteristics	Age [1 year increase vs. Not applicable]	Odds ratio: 1.090 (1.070-1.120) ^§	Bianchetti

If a relevant publication escaped our attention, please contact us.